Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection

2016871 citationsJournal Article

Authors

Abigail S. Caudle · Roche (Switzerland)

Wei Yang · Roche (Switzerland)

Savitri Krishnamurthy · Roche (Switzerland)

Elizabeth A. Mittendorf · Novartis (Switzerland)

Dalliah M. Black · Roche (Switzerland)

Michael Z. Gilcrease · Novartis (Switzerland)

Isabelle Bedrosian ·

Abstract

Marking nodes with biopsy-confirmed metastatic disease allows for selective removal and improves pathologic evaluation for residual nodal disease after chemotherapy.

Topics & Keywords

Breast Cancer Treatment Studies Breast Lesions and Carcinomas Breast Implant and Reconstruction

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 34, Issue 10, pp. 1072-1078

DOI: 10.1200/jco.2015.64.0094

Field-Weighted Citation Impact: 28.31